可替宁检测改善全关节置换术前戒烟效果
该回顾性分析纳入2007至2018年28758例初次全关节置换术患者,其中8.8%(2514例)为吸烟者。术前1个月内接受血清可替宁检测的103例患者,其自我报告的术前戒烟率显著高于未检测组(28.2% vs 15.8%,P = .005)。在自称已戒烟者中,15%的可替宁检测仍为阳性。
要点
- 在28758例初次全关节置换术中,吸烟者占8.8%(2514例),其中103例接受了术前血清可替宁检测。
- 可替宁检测组自我报告术前戒烟率为28.2%,显著高于未检测组的15.8%(P = .005)。
- 在接受可替宁检测的患者中,77%结果为阴性(戒烟),另有15%的可替宁水平在3至8 ng/mL之间,代表被动烟草暴露。
核心结论
- 尽管为帮助患者戒烟做出了共同努力,戒烟在当代全关节置换术实践中仍是一项重大挑战。
- 作者认为,可替宁检测显著提高了吸烟者术前自我报告的戒烟率,并有助于识别15%虚假报告戒烟的患者,以确保对固有风险进行适当咨询。
研究设计与样本
- 回顾性分析,利用医院全关节注册系统识别2007至2018年间接受单侧初次全关节置换术、自我报告为吸烟者(全关节置换术前1年内规律吸烟)的患者。
- 队列平均年龄66岁,55%为女性,平均体重指数为31 kg/m2。
- 将术前1个月内获取血清可替宁检测的患者与未接受可替宁检测的吸烟者进行比较。
- 证据等级:治疗性III级。
主要发现
- 在28758例初次全关节置换术中,8.8%(2514例)为吸烟者,其中103例接受了血清可替宁检测。
- 术前自我报告的戒烟率在未检测组为15.8%,在可替宁检测组为28.2%,可替宁检测组显著改善(P = .005)。
- 在接受可替宁检测的所有患者中,77%为阴性(戒烟),另有15%的可替宁水平在3至8 ng/mL之间,代表被动烟草暴露。
- 在自称已戒烟的患者中,15%的可替宁检测仍为阳性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients who are actively smoking at the time of primary total joint arthroplasty (TJA) are at an increased risk of perioperative complications. Serum cotinine testing is a sensitive and specific method to verify abstinence from smoking and may therefore improve a patient's chance of smoking cessation. The primary purpose of this study was to assess whether cotinine testing improves the self-reported quit rate among smokers before TJA. METHODS: Our hospital performs a high volume of TJAs and documents smoking status at each clinic visit (at 6-month intervals), as well as at the time of surgery through an institutional total joint registry. As part of a retrospective analysis, this information was used to identify all self-reported smokers (regularly cigarette smoking within 1 year of TJA) who underwent unilateral TJA from 2007 to 2018. The cohort had a mean age of 66 years, 55% were female, and the mean body mass index was 31 kg/m2. Patients whose serum cotinine was obtained within 1 month before surgery were then separated from the cohort and compared to the smokers who did not undergo cotinine testing. RESULTS: Of the 28,758 primary TJAs identified, 8.8% (2514) were smokers. Serum cotinine testing was obtained on 103 of these patients. The abstinence rate (by means of self-reporting) before surgery significantly improved from 15.8% to 28.2% in the untested vs cotinine-tested groups, respectively (P = .005). Among all patients who underwent cotinine testing, 77% were negative (abstinent) and an additional 15% had cotinine levels between 3 and 8 ng/mL representing passive tobacco exposure. Among patients who stated they had quit smoking, 15% still had positive cotinine tests. CONCLUSION: Smoking cessation remains a major challenge in contemporary TJA practices despite a concerted effort to help patients quit. Our findings suggest that cotinine testing significantly improves the self-reported quit rates of smokers before surgery and helps identify the 15% who falsely report abstinence to ensure appropriate counseling of inherent risks. LEVEL OF EVIDENCE: Therapeutic level III.
引用
- Hart A, Rainer WG, Taunton MJ, et al. Cotinine Testing Improves Smoking Cessation Before Total Joint Arthroplasty. J Arthroplasty. 2018. PMID: 30579712. doi:10.1016/j.arth.2018.11.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。